ResearcherTaipei Medical University HospitalActive in the last 2 years

Long‐Sheng Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4247-1981; OpenAlex author ID A5102970094. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

GKB202 suppresses endothelin-1/ERK signaling in pancreatic cancer cells: Potential implications for circulating tumor cell regulation. Co-author DOI 10.1016/j.biopha.2025.118341 ↗
Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma-A Systematic Review and Meta-Analysis. Co-author DOI 10.1016/j.ijrobp.2025.02.037 ↗
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal a… Last author DOI 10.1016/j.ejca.2022.01.030 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hongyan Wu · 1 shared paper, 2025 · strength 0.30
- Paper Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma-A Systema… DOI 10.1016/j.ijrobp.2025.02.037 ↗
Hui-Ju Ch’ang · 1 shared paper, 2025 · strength 0.30
- Paper Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma-A Systema… DOI 10.1016/j.ijrobp.2025.02.037 ↗
Chin‐Chu Chen · 1 shared paper, 2025 · strength 0.24
- Paper GKB202 suppresses endothelin-1/ERK signaling in pancreatic cancer cells: Potential implications for circulating tumor c… DOI 10.1016/j.biopha.2025.118341 ↗
Yufang Hu · 1 shared paper, 2025 · strength 0.24
- Paper GKB202 suppresses endothelin-1/ERK signaling in pancreatic cancer cells: Potential implications for circulating tumor c… DOI 10.1016/j.biopha.2025.118341 ↗
Shin‐E Wang · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Shih‐Ming Hsu · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Yuan‐Hung Wu · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Chung‐Pin Li · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Yee Chao · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.